Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, Casucci M, De Angelis B, Donnadieu E, Espie D, Greco B, Groen R, Huppa JB, Kantari-Mimoun C, Laugel B, Mantock M, Markman JL, Morris E, Quintarelli C, Rade M, Reiche K, Rodriguez-Garcia A, Rodriguez-Madoz JR, Ruggiero E, Themeli M, Hudecek M, Marchiq I.
Guedan S, et al. Among authors: bonini c.
J Immunother Cancer. 2022 May;10(5):e003487. doi: 10.1136/jitc-2021-003487.
J Immunother Cancer. 2022.
PMID: 35577501
Free PMC article.
Review.